Weinhold Legal has advised Eureking on the acquisition of SCT Cell Manufacturing from PPF Biotech.
SCT Cell Manufacturing is a service and logistics organization offering cell therapy and viral vector manufacturing services.
Eureking is an investment company with shares traded on the Paris Stock Exchange.
According to Weinhold Legal, “the transaction structure envisages that PPF Biotech will contribute a portion of its shares to Eureking, thereby acquiring a minority stake.” The proposed transaction would amount to nearly EUR 20 million.
The Weinhold Legal team included Partner Martin Lukas and Senior Managing Associate Jakub Nedoma, Senior Associate Michal Przeczek, and Junior Associate Matej Novak.
